Predicting Outcomes and Tailoring Therapy in the Diagnosis and Treatment of IBD

Por Scherl, Ellen J., Seidman, Ernest G., Wolf, Douglas C.
Publicado em 2007

Community Perspectives: Combining Serology, Genetics, and Inflammation Markers for the Diagnosis of IBD and Differentiation Between CD and UC

Por Wolf, Douglas C., Abraham, Bincy P., Afzali, Anita, Allegretti, Paul D., Arai, Ronen
Publicado em 2012

Transcriptional Modulation of the ERK1/2 MAPK and NF-κB Pathways in Human Urothelial Cells After Trivalent Arsenical Exposure: Implications for Urinary Bladder Cancer

Por Bailey, Kathryn A., Wallace, Kathleen, Smeester, Lisa, Thai, Sheau-Fung, Wolf, Douglas C., Edwards, Stephen W., Fry, Rebecca C.
Publicado em 2012

Identification and Characterization of Adverse Effects in 21(st) Century Toxicology

Por Keller, Douglas A., Juberg, Daland R., Catlin, Natasha, Farland, William H., Hess, Frederick G., Wolf, Douglas C., Doerrer, Nancy G.
Publicado em 2012

Effects of Prenatal Exposure to a Low Dose Atrazine Metabolite Mixture on Pubertal Timing and Prostate Development of Male Long Evans Rats

Por Stanko, Jason P., Enoch, Rolondo R., Rayner, Jennifer L., Davis, Christine C., Wolf, Douglas C., Malarkey, David E., Fenton, Suzanne E.
Publicado em 2010

Placental Transfer of Anti-Tumor Necrosis Factor Agents in Pregnant Patients with Inflammatory Bowel Disease

Por Mahadevan, Uma, Wolf, Douglas C., Dubinsky, Marla, Cortot, Antoine, Lee, Scott D., Siegel, Corey A., Ullman, Thomas, Glover, Sarah, Valentine, John F., Rubin, David T., Miller, Jocelyn, Abreu, Maria T.
Publicado em 2012

A predictive data-driven framework for endocrine prioritization: a triazole fungicide case study

Por Paul Friedman, Katie, Papineni, Sabitha, Marty, M. Sue, Yi, Kun Don, Goetz, Amber K., Rasoulpour, Reza J., Kwiatkowski, Pat, Wolf, Douglas C., Blacker, Ann M., Peffer, Richard C.
Publicado no Crit Rev Toxicol (2016)

Four-Year Maintenance Treatment With Adalimumab in Patients with Moderately to Severely Active Ulcerative Colitis: Data from ULTRA 1, 2, and 3

Por Colombel, Jean-Frederic, Sandborn, William J, Ghosh, Subrata, Wolf, Douglas C, Panaccione, Remo, Feagan, Brian, Reinisch, Walter, Robinson, Anne M, Lazar, Andreas, Kron, Martina, Huang, Bidan, Skup, Martha, Thakkar, Roopal B
Publicado no Am J Gastroenterol (2014)

Illustrative case using the RISK21 roadmap and matrix: prioritization for evaluation of chemicals found in drinking water

Por Wolf, Douglas C., Bachman, Ammie, Barrett, Gordon, Bellin, Cheryl, Goodman, Jay I., Jensen, Elke, Moretto, Angelo, McMullin, Tami, Pastoor, Timothy P., Schoeny, Rita, Slezak, Brian, Wend, Korinna, Embry, Michelle R.
Publicado no Crit Rev Toxicol (2016)

Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: A case study with phenobarbital as a model constitutive androstane receptor (CAR) activato...

Por Elcombe, Clifford R., Peffer, Richard C., Wolf, Douglas C., Bailey, Jason, Bars, Remi, Bell, David, Cattley, Russell C., Ferguson, Stephen S., Geter, David, Goetz, Amber, Goodman, Jay I., Hester, Susan, Jacobs, Abigail, Omiecinski, Curtis J., Schoeny, Rita, Xie, Wen, Lake, Brian G.
Publicado em 2013

Finfish and aquatic invertebrate pathology resources for now and the future

Por Spitsbergen, Jan M., Blazer, Vicki S., Bowser, Paul R., Cheng, Keith C., Cooper, Keith R., Cooper, Timothy K., Frasca, Salvatore, Groman, David B., Harper, Claudia M., (Mac) Law, Jerry M., Marty, Gary D., Smolowitz, Roxanna M., Leger, Judy St., Wolf, Douglas C., Wolf, Jeffrey C.
Publicado em 2008